Ashish                                              Deshmukh                                            to  Cross-Sectional Studies
                            
                            
                                This is a "connection" page, showing publications  Ashish                                              Deshmukh                                            has written about  Cross-Sectional Studies.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.045
         
        
        
     
 
    
        
        - 
            Prevalence and concordance of oral and genital HPV by sexual orientation among US men. JNCI Cancer Spectr. 2023 Jan 03; 7(1).
            
            
                Score: 0.130
             
- 
            Oropharyngeal Cancer Incidence and Mortality Trends in All 50 States in the US, 2001-2017. JAMA Otolaryngol Head Neck Surg. 2022 02 01; 148(2):155-165.
            
            
                Score: 0.122
             
- 
            Analysis of Suicide After Cancer Diagnosis by US County-Level Income and Rural vs Urban Designation, 2000-2016. JAMA Netw Open. 2021 Oct 01; 4(10):e2129913.
            
            
                Score: 0.119
             
- 
            Evaluation of Cervical Cancer Screening Uptake and Adherence Among Women Without Human Papillomavirus Vaccination in the US. JAMA Netw Open. 2021 Oct 01; 4(10):e2131129.
            
            
                Score: 0.119
             
- 
            Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States. JAMA Netw Open. 2021 Sep 01; 4(9):e2124502.
            
            
                Score: 0.118
             
- 
            Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey. Lancet Public Health. 2020 09; 5(9):e484-e492.
            
            
                Score: 0.110
             
- 
            Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women. JAMA Netw Open. 2019 12 02; 2(12):e1918571.
            
            
                Score: 0.105
             
- 
            National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers. JAMA Intern Med. 2024 Jun 01; 184(6):671-679.
            
            
                Score: 0.036
             
- 
            Trends in Oral Tongue Cancer Incidence in the US. JAMA Otolaryngol Head Neck Surg. 2024 May 01; 150(5):436-443.
            
            
                Score: 0.036
             
- 
            Consumption of Health-Related Videos and Human Papillomavirus Awareness: Cross-Sectional Analyses of a US National Survey and YouTube From the Urban-Rural Context. J Med Internet Res. 2024 Jan 15; 26:e49749.
            
            
                Score: 0.035
             
- 
            Barriers and facilitators to anal cancer screening among people living with HIV in Puerto Rico. BMC Public Health. 2023 10 06; 23(1):1940.
            
            
                Score: 0.034
             
- 
            A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study. Cancer Epidemiol Biomarkers Prev. 2022 12 05; 31(12):2185-2191.
            
            
                Score: 0.032
             
- 
            Antihypertensive drug use and blood pressure control among stroke survivors in the United States: NHANES 2003-2014. J Clin Hypertens (Greenwich). 2019 06; 21(6):766-773.
            
            
                Score: 0.025
             
- 
            Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study. Gynecol Oncol. 2019 05; 153(2):266-270.
            
            
                Score: 0.025